Lilly Invests $6.5 B to Build API Plant in Houston
Houston, Texas – September 23, 2025 — Eli Lilly and Company (NYSE: LLY) will invest $6.5 billion to build...
Advertisement
Bayer’s Elinzanetant Secures CHMP Backing for Menopause Therapy
Berlin, Germany – September 19, 2025 — Bayer announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Gallant Advances First Ready-to-Use Veterinary Stem Cell Therapy
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
Micromedex Launches AI Tool for Drug Safety and Care
ANN ARBOR, Mich., September 23, 2025 – Micromedex has launched an AI-powered search capability to provide clinicians with faster,...
Alzheimer’s and Eye Drug Updates Highlight InMed FY2025
Vancouver, BC, September 23, 2025 – InMed Pharmaceuticals has reported its full‐year fiscal 2025 financial results and provided a...
Pfizer Expands Obesity Pipeline with $4.9B Metsera Acquisition
NEW YORK, September 22, 2025 – In a landmark move shaping the future of obesity and cardiometabolic disease treatments,...
FDA Clears Merck’s Keytruda QLEX for Subcutaneous Solid Tumor Use
RAHWAY, N.J. – September 20, 2025 — Merck (NYSE: MRK) announced that the U.S. Food and Drug Administration (FDA)...
High ESA Failure Rates Revealed in Lower-Risk MDS Real-World Study
September 22, 2025 — Florida, USA — A recent real-world retrospective study of 359 adult patients with lower-risk myelodysplastic...
European Commission Approves Henlius and Organon’s Biosimilars for Bone Disorders
SHANGHAI, China & JERSEY CITY, NJ – September 19, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN)...
Phase III Study Shows Giredestrant Boosts Breast Cancer Survival
Basel, Switzerland — September 22, 2025 — Positive phase III trial results from the evERA study reveal that the...
Advertisement
